title: Calcium levels in rat submandibular gland and saliva after sympathetic nerve stimulation in the presence of alpha, beta 1 and beta 2-adrenergic antagonists.
abstract: Calcium concentration was reduced by 51 per cent compared with unstimulated contralateral glands after 60-min of electrical stimulation to the sympathetic nerve. When the alpha-adrenergic antagonists, phentolamine or phenoxybenzamine, were given 20 min before stimulation, the decrease in glandular calcium concentration (45-47 per cent) was similar to that after nerve stimulation alone; with the selective beta 2-adrenergic antagonist added to the phentolamine, the percentage decrease was similar to that found after phentolamine and sympathetic nerve stimulation only. When atenolol, a beta 1-adrenergic antagonist, was given with phentolamine, there was no secretion after subsequent nerve stimulation, nor was calcium concentration different from that of unstimulated glands. When propranolol (3 mg/kg, body wt), or atenolol + butoxamine (3 mg/kg, body wt), was given prior to stimulation there was a decrease of 21-22 per cent in gland-calcium concentration. Calcium concentration of nerve-stimulated saliva was nearly 6 m-equiv./l, and twice as high with phentolamine prior to stimulation; for butoxamine together with phentolamine the change was similar to that with phentolamine alone. When beta-adrenergic antagonists were given prior to nerve stimulation, concentration of the saliva was either unchanged (propranolol) from that with nerve stimulation alone or somewhat decreased (atenolol + butoxamine). Thus sympathetic stimulation results in activation of alpha and beta 1-adrenoceptors; calcium secretion is principally regulated by the beta-adrenoceptors, and beta 1-receptors have the principal role.
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D051381:Rats; D012463:Saliva / Q000187:drug effects / Q000378:metabolism*; D013363:Submandibular Gland / Q000187:drug effects / Q000378:metabolism*; D013564:Sympathetic Nervous System / Q000502:physiology*; D013997:Time Factors
chemical_list: D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002118:Calcium